A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone.
AUTOR(ES)
Figueiredo, A M
RESUMO
A beta-lactam-resistant serotype 23F Streptococcus pneumoniae clinical isolate from the cerebrospinal fluid of a pediatric patient from California is unusual in that the MICs of cefotaxime and ceftriaxone (2.5 micrograms/ml each) are higher than that of benzylpenicillin (0.3 micrograms/ml); the isolate also has patterns of penicillin-binding proteins and of cell wall peptides which are atypical compared with those of previously examined penicillin-resistant pneumococci.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=189481Documentos Relacionados
- Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.
- In vitro assay to demonstrate high-level erythromycin resistance of a clinical isolate of Treponema pallidum.
- High-level resistance to cefotaxime and ceftazidime in Klebsiella pneumoniae isolates from Cleveland, Ohio.
- High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium.
- Multiple Resistance Mechanisms among Aspergillus fumigatus Mutants with High-Level Resistance to Itraconazole